Charles Matine Bionik Laboratories Corp. (BNKL) insider trading activity

BNKL Quotes by TradingView

Charles Matine is Director of Bionik Laboratories Corp.. Currently has a direct ownership of 206,985 shares of BNKL, which is worth approximately $0. The most recent transaction as insider was on Jun 09, 2023, when has been sold 180,555 shares (Common Stock, par value $0.001 per share) at a price of $0.6 per share, resulting in proceeds of $108,333. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 207K
0% 3M change
0% 12M change
Total Value Held $0

Charles Matine Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 09 2023
BUY
Open market or private purchase
$108,333 $0.6 p/Share
180,555 Added 46.59%
206,985 Common Stock, par valu...
Mar 29 2021
BUY
Open market or private purchase
-
26,430 Added 50.0%
26,430 Common Stock, par valu...
CM

Charles Matine

Director
Toronto, A6

Track Institutional and Insider Activities on BNKL

Follow Bionik Laboratories Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BNKL shares.

Notify only if

Insider Trading

Get notified when an Bionik Laboratories Corp. insider buys or sells BNKL shares.

Notify only if

News

Receive news related to Bionik Laboratories Corp.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BNKL